1325189-13-6

Basic information

• Product Name: 3-[7-(4-methylpiperazin-1-yl)furo[2,3-c]pyridin-5-yl]-5-phenyl-1,3-oxazolidin-2-one
• Synonyms: 3-[7-(4-methylpiperazin-1-yl)furo[2,3-c]pyridin-5-yl]-5-phenyl-1,3-oxazolidin-2-one
• CAS NO: 1325189-13-6
• Molecular Weight: 378.431
• Mol File: 1325189-13-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 3-[7-(4-methylpiperazin-1-yl)furo[2,3-c]pyridin-5-yl]-5-phenyl-1,3-oxazolidin-2-one(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[7-(4-methylpiperazin-1-yl)furo[2,3-c]pyridin-5-yl]-5-phenyl-1,3-oxazolidin-2-one(1325189-13-6)
• EPA Substance Registry System: 3-[7-(4-methylpiperazin-1-yl)furo[2,3-c]pyridin-5-yl]-5-phenyl-1,3-oxazolidin-2-one(1325189-13-6)

Safety Data

• Hazardous Substances Data: 1325189-13-6(Hazardous Substances Data)

Upstream product

• 1325190-09-7 5,7-dibromofuro[2,3-c]pyridine 
• 1325190-07-5 2,6-dibromo-4-[2-(trimethylsilyl)ethynyl]pyridin-3-ol 
• 1325190-11-1 C₁₂H₁₄BrN₃O 
• 7693-77-8 5-phenyloxazolidin-2-one 
• 478148-75-3 2,6-dibromo-4-iodopyridin-3-ol 
• 6602-33-1 2,6-dibromopyridin-3-ol 
• 7568-93-6 2-Amino-1-phenylethanol 
• 109-00-2 3-HYDROXYPYRIDINE 

Relevant articles and documents

5-HT RECEPTOR MODULATORS

The invention relates to compounds of formula (I), useful for treating disorders mediated by the 5-hydroxytryptamine (serotonin) receptor IB (5-HT1B), e.g. vascular disorders, cancer and CNS disorders. The invention also provides methods of treating such disorders, and compounds and compositions etc. for their treatment.